The nutritional status of patients submitted to hematopoietic stem cell transplant is considered an independent risk factor, which may influence on quality of life and tolerance to the proposed treatment. The impairment of nutritional status during hematopoietic stem cell transplant occurs mainly due to the adverse effects resulting from conditioning to which the patient is subjected. Therefore, adequate nutritional evaluation and follow-up during hematopoietic stem cell transplant are essential. To emphasize the importance of nutritional status and body composition during treatment, as well as the main characteristics related to the nutritional assessment of the patient, the Brazilian Consensus on Nutrition in Hematopoietic Stem Cell Transplant: Adults was prepared, aiming to standardize and update Nutritional Therapy in this area. Dietitians, nutrition physicians and hematologists from 15 Brazilian centers thar are references in hematopoietic stem cell transplant took part.
Objective: To determine whether preoperative anthropometric and computed tomography (CT) measurements of body composition can predict postoperative morbidity and mortality in patients with gastric or esophageal cancer. Materials and Methods: This was a retrospective study in which we reviewed the medical records and abdominal CT scans of patients with gastric or esophageal cancer who underwent surgery in 2015 at a cancer center. CT scans performed during routine preoperative evaluation were retrospectively assessed to measure the area of lean body mass at the level of the third lumbar vertebra, as well as the area of visceral and subcutaneous fat. Results: Seventy patients were included in the study. The mean age was 59.9 years (range, 33-82 years), and 47 patients (67.1%) were men. The mean postoperative follow-up period was 14.9 months. Neither postoperative morbidity nor postoperative mortality correlated significantly with gender, age, the type of primary tumor, the presence of comorbidities, smoking status, body mass index, nutritional status, or visceral fat area. The survival rate was higher for patients with normal lean body mass than for those with low lean body mass (hazard ratio = 0.116; 95% confidence interval: 0.015-0.906; p = 0.040). Conclusion: Our data suggest that lean body mass can be a relevant prognostic factor in patients with gastric or esophageal cancer, and that CT measurements should be included in the routine preoperative evaluation, because it may provide information that aids nutritional and clinical care for these patients.
Background Malnutrition in pediatric oncology inpatients can cause several complications, and the early identification of inpatients at nutritional risk with screening tool is crucial. Objective The aim of this study was to evaluate StrongKids and SGNA in order to analyze their performance and efficacy in pediatric inpatients undergoing oncological treatment and compare with objective assessment. Materials and Methods This was a cross-sectional study with pediatric oncology inpatients, of both sexes, admitted to A.C. Camargo Cancer Center. Data collection was conducted during the first hospital admission appointment, when StrongKids and SGNA were applied, and anthropometric data were collected. Results Sixty inpatients with an average age of 8.49 years old were evaluated, and 21,6% inpatients were diagnosed with malnutrition. SGNA and StrongKids shows a sensitivity of 92.3% and 84.6%, respectively. In the comparison of both tools, an adequate accuracy of 81.67% was detected. In addition, a significant kappa (κ) value was obtained (p = 0.021) for the evaluation comparing SGNA and the objective assessment, showing reasonable concordance (κ = 0.235). Conclusion Both nutritional screening tools showed a good performance with respect to sensitivity, compared with the objective assessment. Neither method showed a satisfactory accuracy when applied to pediatric oncology inpatients.
OBJECTIVE: Colorectal cancer is the third most diagnosed malignant neoplasm in the world and the fourth leading cause of cancer mortality. The loss of muscle mass in oncological patients is the main aspect of cancer-related malnutrition. Associations between sarcopenia and poor outcomes, such as high postoperative mortality, chemotherapy toxicity, and reduced survival, have been recently described. The aim of this study was to prospectively assess the prevalence of preoperative sarcopenia in patients with colorectal cancer using validated methods to evaluate muscle strength, muscle mass, and physical performance. METHODOLOGY: This study included patients with colorectal cancer undergoing oncological staging at a Cancer Center in Brazil from May 2019 to March 2020 who had images from abdominal computed tomography available for analysis of body composition. The muscle strength test, physical performance, referred fatigue, and clinical and nutritional data were evaluated. RESULTS: A total of 31 patients were included, and most were diagnosed with colon cancer (77.4%) and clinical stage II in 41.9% of cases. The prevalence of probable sarcopenia was 22.6%; of these patients, sarcopenia was confirmed in 19.4%, and ultimately, 9.7% of the sample was classified as severe sarcopenia. We did not find a significant association between the presence of sarcopenia in our sample and age, sex, tumor staging, nutritional characteristics, referred patient fatigue, or postoperative complications. CONCLUSION: Considering the criteria established by the EWGSOP, the prevalence of preoperative sarcopenia in colorectal cancer patients was 19.4%.
Introduction:Malnutrition affects an average of 20-80% of cancer patients, leading to an impaired healing process, increased infection rates and hospital costs, and negative impacts on clinical results. Oral nutritional supplements (ONS) help to increase the patients caloric and protein supplies, promoting recovery of nutritional status. In order to have good adherence to the ONS, it is necessary that the multidisciplinary team assigned is aligned with regard to the information transferred to the patient. Objectives: This study aimed to assess the technical knowledge about oral nutritional therapy (ONT) among physicians and the nursing staff at a private institution. Materials and Methods: This was a descriptive cross-sectional study. The physicians and residents as well as the nursing staff who work in clinical patient care were invited to answer a semi-structured questionnaire to assess their technical knowledge regarding ONT. Results: This study evaluated 105 professionals. Most physicians and nursing staff stated that ONS is a food supplement. Although they reported not having had technical training on the subject, most of them felt capable of prescribing and providing guidance participants neglected symptoms and conditions relevant to the nutritional status of the patient, such ascites, enteral nutritional therapy and home parenteral nutrition, concomitant chemotherapy/radiotherapy, and emesis. Conclusion: Information about ONS among medical and nursing professionals varies greatly. Interdisciplinary technical training is essential for the success of ONT as a tool for preventing and combating malnutrition.
Objective: To correlate body composition measures, based on computed tomography (CT) analysis of muscle mass and adipose tissue, with disease-free survival in breast cancer patients. Materials and Methods: This single-center retrospective study included 262 female patients with nonmetastatic breast cancer. Body composition was assessed on a pretreatment CT scan (at the L3 level). The analysis included quantification of the areas of subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT), and skeletal muscle mass, as well as of the mean skeletal muscle density. The VAT/SAT ratio, skeletal mass index (SMI), and skeletal muscle gauge (SMG) were calculated. Results: Of the 262 patients evaluated, 175 (66.8%) were classified as overweight or obese on the basis of their body mass index. We observed low SMI in 35 patients (13.4%) and elevated VAT in 123 (46.9%). Disease-free survival was significantly shorter in the patients who underwent neoadjuvant chemotherapy (p = 0.044), in those with a low SMI (p = 0.006), in those with low SMG (p = 0.013), and in those with a low VAT/SAT ratio (p = 0.050). In a multivariate analysis, only SMG, the VAT/SAT ratio, and having undergone neoadjuvant chemotherapy retained their statistical significance. Conclusion: Our results confirm that low SMG and the VAT/SAT ratio can be used as imaging biomarkers to assess prognosis in patients with nonmetastatic breast cancer.
Objetivo: Avaliar o estado nutricional de pacientes em quimioterapia. Material e métodos: 1222 pacientes foram avaliados através da avaliação subjetiva global produzida pelo paciente (ASG-PPP) no primeiro dia de quimioterapia. Verificaram-se os tipos de tumores e estadiamento do câncer e os sintomas apresentados pelos pacientes no inicio do tratamento. Resultados: 13,8% da amostra encontrou-se em desnutrição e destes os tipos de tumores mais prevalentes foram pele não melanoma, tumores gastrintestinais e pulmão. 40,8% dos pacientes estavam em sobrepeso e obesidade e o câncer de mama foi o mais prevalente neste grupo. Os sintomas mais relatados no inicio do tratamento foram inapetência (13%) e empachamento (10,6%). Conclusão: o estudo ressalta a importância de realizar um método de triagem nutricional para avaliar pacientes oncológicos em risco nutricional durante o a quimioterapia.Palavras-chave: câncer, quimioterapia, avaliação nutricional.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.